Mecure H1 2025
Mecure is one of the 5 listed players in the pharma space on the NGX.
In fhis episode i discuss its H1 2025 earnings: Revenue split and pain points.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.